| |
| |
|
| Insider
Information: |
Newhall Charles W III |
| Relationship: |
Director |
| City: |
Baltimore |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
17 |
|
| Direct
Shares |
1,746,114 |
|
|
Indirect Shares
|
133,127,843 |
|
|
| Direct
Value |
$3,532,214 |
|
|
|
Indirect Value
|
$195,937,495 |
|
|
| Total
Shares |
134,873,957 |
|
|
| Total
Value |
$199,469,709 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -52.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Welltek Incorporated |
WTKND |
Former 10% Owner |
2004-05-06 |
1,149 |
2004-09-28 |
14,470 |
Premium* |
|
|
Aradigm Corp |
ARDM |
10% Owner |
2003-12-11 |
51 |
2004-02-20 |
0 |
Premium* |
|
|
FoxHollow Technologies |
FOXH |
Former 10% Owner |
2004-11-02 |
0 |
2004-11-02 |
1,804,462 |
Premium* |
|
|
DZS Inc |
DZSI |
10% Owner |
2005-02-10 |
0 |
2008-03-10 |
12,051,646 |
Premium* |
|
|
Occam Networks Inc |
OCNW |
Former 10% Owner |
2006-11-07 |
1,623,555 |
2006-04-07 |
0 |
Premium* |
|
|
Gyre Therapeutics |
GYRE |
10% Owner |
2006-04-12 |
0 |
2008-01-17 |
4,565,512 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2009-01-30 |
2,083,426 |
Premium* |
|
|
Vonage Holdings Corp |
VG |
10% Owner |
2006-05-30 |
0 |
2011-03-11 |
22,793 |
Premium* |
|
|
Innerworkings Inc |
INWK |
10% Owner |
2007-11-16 |
0 |
2012-03-28 |
15,000 |
Premium* |
|
|
Pharmos Corp |
PARS |
Director, 10% Owner |
|
0 |
2009-05-08 |
14,435,105 |
Premium* |
|
|
Amicus Therapeutics Inc |
FOLD |
10% Owner |
2007-06-05 |
0 |
2012-03-07 |
4,584,311 |
Premium* |
|
|
Echo Global Logistics Inc |
ECHO |
10% Owner |
2012-02-28 |
95 |
2012-02-28 |
0 |
Premium* |
|
|
Financial Engines, Inc. |
FNGN |
10% Owner |
|
0 |
2010-08-30 |
3,481,941 |
Premium* |
|
|
Groupon, Inc. |
GRPN |
10% Owner |
|
0 |
2011-11-03 |
87,184,956 |
Premium* |
|
|
Hyperion Therapeutics Inc |
HPTX |
10% Owner |
|
0 |
2012-07-31 |
2,884,221 |
Premium* |
|
|
Supernus Pharmaceuticals Inc |
SUPN |
Director |
2024-02-23 |
120,975 |
2015-06-15 |
0 |
Premium* |
|
|
Vitae Pharmaceuticals, Inc |
VTAE |
Director |
2015-07-01 |
289 |
2015-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
182 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DZSI |
DZS Inc |
10% Owner |
– – • |
2005-06-06 |
4 |
B |
$2.45 |
$88,886 |
I/I |
36,280 |
4,859,249 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2008-03-03 |
4 |
B |
$1.10 |
$90,522 |
I/I |
82,345 |
8,718,320 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2008-02-07 |
4 |
B |
$1.09 |
$92,296 |
I/I |
84,940 |
7,921,808 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2008-03-07 |
4 |
B |
$1.11 |
$93,332 |
I/I |
84,250 |
8,890,337 |
1.5 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2007-06-05 |
4 |
OE |
$6.38 |
$96,116 |
I/I |
15,077 |
3,665,565 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2007-06-05 |
4 |
S |
$15.00 |
$96,120 |
I/I |
(6,408) |
3,659,157 |
0 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-11-15 |
4 |
B |
$1.25 |
$99,313 |
I/I |
79,450 |
7,555,150 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-11-20 |
4 |
B |
$1.25 |
$101,332 |
I/I |
81,300 |
7,743,750 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2008-03-10 |
4 |
B |
$1.11 |
$110,570 |
I/I |
100,000 |
8,940,337 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2005-05-10 |
4 |
B |
$2.45 |
$114,207 |
I/I |
46,615 |
4,691,078 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2008-02-11 |
4 |
B |
$1.09 |
$120,001 |
I/I |
110,600 |
8,035,308 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2008-02-12 |
4 |
B |
$1.08 |
$123,318 |
I/I |
114,300 |
8,092,458 |
1.5 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2020-02-21 |
4 |
A |
$23.99 |
$125,012 |
D/D |
5,211 |
97,509 |
0 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2008-02-13 |
4 |
B |
$1.09 |
$125,147 |
I/I |
114,300 |
8,149,608 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2008-02-19 |
4 |
B |
$1.07 |
$130,781 |
I/I |
122,718 |
8,326,128 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2008-02-08 |
4 |
B |
$1.13 |
$131,485 |
I/I |
116,400 |
7,980,008 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-08-17 |
4 |
B |
$1.20 |
$131,632 |
I/I |
109,785 |
7,133,806 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2008-02-06 |
4 |
B |
$1.10 |
$132,559 |
I/I |
120,300 |
7,879,338 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2008-03-05 |
4 |
B |
$1.08 |
$133,274 |
I/I |
123,700 |
8,808,170 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-11-26 |
4/A |
B |
$1.25 |
$135,750 |
I/I |
108,600 |
7,832,335 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2008-02-29 |
4 |
B |
$1.11 |
$136,316 |
I/I |
122,432 |
8,677,148 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2008-02-14 |
4 |
B |
$1.20 |
$137,480 |
I/I |
114,300 |
8,233,908 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-08-27 |
4 |
B |
$1.20 |
$139,894 |
I/I |
116,949 |
7,243,532 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-11-19 |
4 |
B |
$1.25 |
$140,606 |
I/I |
112,900 |
7,703,100 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2008-02-22 |
4 |
B |
$1.09 |
$142,152 |
I/I |
130,200 |
8,440,404 |
1.5 |
- |
|
182 Records found
|
|
Page 5 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
